(NASDAQ: NTRA) Natera's forecast annual revenue growth rate of 15.71% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.8%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.76%.
Natera's revenue in 2025 is $1,831,000,000.On average, 6 Wall Street analysts forecast NTRA's revenue for 2025 to be $284,252,429,251, with the lowest NTRA revenue forecast at $280,125,308,870, and the highest NTRA revenue forecast at $286,446,050,058. On average, 7 Wall Street analysts forecast NTRA's revenue for 2026 to be $328,522,469,045, with the lowest NTRA revenue forecast at $319,928,636,940, and the highest NTRA revenue forecast at $336,656,958,456.
In 2027, NTRA is forecast to generate $393,193,933,358 in revenue, with the lowest revenue forecast at $373,784,656,291 and the highest revenue forecast at $419,009,566,320.